TBA 2018

London, UK

 

Tumour Models London 2017: Your Highlights

Enhancing the Predictive Confidence of Preclinical & Translational Cancer Research

For the last 6 years the Tumor Models Conference has sat at the interface of innovation in model development and therapeutic application. It continues to serve as an open and collaborative platform enabling pharmaceutical scientists, model developers and academicians to explore recent advances in the range of in-vitro and in-vivo systems.

The meeting will once again delve into how these models are successfully being utilized for discovery, safety assessment and to enhance confidence in clinical translation of cancer research.

 

What makes this event unique?

  •  A concerted attempt to provide an ambiance at the conference that encourages interaction, exchange of ideas and networking opportunities among all participants

  • A high-quality scientific program dedicated to exploring the applicability of the range of IO and oncology models

  • A multidisciplinary mix of participants representing consortia, leading scientists and pharmaceutical business leaders

 


PROUD TO PARTNER WITH:

 

 crownbio-logo  Jackson Laborartory

Lead Partner

Programme Partner

 champions oncology  nanostring

Programme Partner

Programme Partner

 Imprimer  Miltenyi_Biotec_logo

Spotlight Partner

Spotlight Partner

repositive-web-644x498

Mitra

Spotlight Partner

Exhibitor

AAEAAQAAAAAAAAj8AAAAJGFkM2Q5NDkwLTZhOTQtNDE4Yi05NjExLTdlMTU1MmNlM2VkNw

Exhibitor

OFFICIAL MEDIA PARTNERS

Print  CRISPR Congress - LabioTech

 


PART OF TUMOR MODELS SERIES

Tumor models SF logo   Tumor Models Boston Logo no year